Center for Vaccinology (CEVAC)

Ghent 9000

0 studies enrolling now · 3 studies all time

What they study most

Covid-19 Prevention, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19

Studies at this site

• A Study of 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older — Completed
• A Study of Ad26.COV2.S in Adults (COVID-19) — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed